Geneos Wealth Management Inc. My Md Pharmaceuticals, Inc. Transaction History

Geneos Wealth Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$1.44 - $2.26 $324 - $508	225 Added 45.0%	725 $1,000
Q1 2023 Apr 25, 2023	SELL	$1.1 - $2.86 $247 - $643	-225 Reduced 31.03%	500 $0
Q3 2022 Nov 14, 2022	BUY	$2.22 - $82.2 $499 - $18,495	225 Added 45.0%	725 $1,000
Q1 2022 May 16, 2022	BUY	$3.34 - $6.05 $1,670 - $3,025	500 New	500 $2,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.